List of Tables
    Table 1. Palonosetron CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Palonosetron Market Trends
    Table 3. Palonosetron Market Drivers
    Table 4. Palonosetron Market Challenges
    Table 5. Palonosetron Market Restraints
    Table 6. Global Palonosetron Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Palonosetron Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Palonosetron Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Palonosetron Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Palonosetron Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Palonosetron Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Palonosetron Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Palonosetron Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Palonosetron Sales Share by Manufacturer, 2017-2022
    Table 15. Global Palonosetron Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Palonosetron Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Palonosetron by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Palonosetron as of 2021)
    Table 18. Top Players of Palonosetron in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Palonosetron Product Type
    Table 20. Date of International Manufacturers Enter into Palonosetron Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Palonosetron Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Palonosetron Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Palonosetron Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Palonosetron Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Palonosetron Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Palonosetron Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Palonosetron Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Palonosetron Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Palonosetron Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Palonosetron Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Palonosetron Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Palonosetron Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Palonosetron Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Palonosetron Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Palonosetron Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Palonosetron Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Palonosetron Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Palonosetron Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Palonosetron Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Palonosetron Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Helsinn Therapeutics Corporation Information
    Table 43. Helsinn Therapeutics Description and Business Overview
    Table 44. Helsinn Therapeutics Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Helsinn Therapeutics Palonosetron Product
    Table 46. Helsinn Therapeutics Recent Development
    Table 47. Teva Corporation Information
    Table 48. Teva Description and Business Overview
    Table 49. Teva Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Teva Product
    Table 51. Teva Recent Development
    Table 52. Dr. Reddys Laboratories Corporation Information
    Table 53. Dr. Reddys Laboratories Description and Business Overview
    Table 54. Dr. Reddys Laboratories Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Dr. Reddys Laboratories Product
    Table 56. Dr. Reddys Laboratories Recent Development
    Table 57. Cipla Corporation Information
    Table 58. Cipla Description and Business Overview
    Table 59. Cipla Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Cipla Product
    Table 61. Cipla Recent Development
    Table 62. Pfizer Corporation Information
    Table 63. Pfizer Description and Business Overview
    Table 64. Pfizer Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Pfizer Product
    Table 66. Pfizer Recent Development
    Table 67. Sandoz Corporation Information
    Table 68. Sandoz Description and Business Overview
    Table 69. Sandoz Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Sandoz Product
    Table 71. Sandoz Recent Development
    Table 72. Aurobindo Corporation Information
    Table 73. Aurobindo Description and Business Overview
    Table 74. Aurobindo Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Aurobindo Product
    Table 76. Aurobindo Recent Development
    Table 77. Sagent Pharmaceuticals Corporation Information
    Table 78. Sagent Pharmaceuticals Description and Business Overview
    Table 79. Sagent Pharmaceuticals Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Sagent Pharmaceuticals Product
    Table 81. Sagent Pharmaceuticals Recent Development
    Table 82. Fresenius Kabi Corporation Information
    Table 83. Fresenius Kabi Description and Business Overview
    Table 84. Fresenius Kabi Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Fresenius Kabi Product
    Table 86. Fresenius Kabi Recent Development
    Table 87. Qilu Pharmaceutical Corporation Information
    Table 88. Qilu Pharmaceutical Description and Business Overview
    Table 89. Qilu Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Qilu Pharmaceutical Product
    Table 91. Qilu Pharmaceutical Recent Development
    Table 92. Jiangsu Aosaikang Pharmaceutical Corporation Information
    Table 93. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
    Table 94. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Jiangsu Aosaikang Pharmaceutical Product
    Table 96. Jiangsu Aosaikang Pharmaceutical Recent Development
    Table 97. Sichuan Hairong Pharmaceutical Corporation Information
    Table 98. Sichuan Hairong Pharmaceutical Description and Business Overview
    Table 99. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Sichuan Hairong Pharmaceutical Product
    Table 101. Sichuan Hairong Pharmaceutical Recent Development
    Table 102. Exela Pharma Corporation Information
    Table 103. Exela Pharma Description and Business Overview
    Table 104. Exela Pharma Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Exela Pharma Product
    Table 106. Exela Pharma Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Palonosetron Customers List
    Table 110. Palonosetron Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Palonosetron Product Picture
    Figure 2. Global Palonosetron Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Palonosetron Market Size 2017-2028 (US$ Million)
    Figure 4. Global Palonosetron Sales 2017-2028 (K Units)
    Figure 5. United States Palonosetron Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Palonosetron Market Size 2017-2028 (US$ Million)
    Figure 7. United States Palonosetron Sales 2017-2028 (K Units)
    Figure 8. United States Palonosetron Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Palonosetron Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Palonosetron Report Years Considered
    Figure 11. Product Picture of Injection 0.25 mg/5 mL
    Figure 12. Product Picture of Injection 20 mcg/kg (max 1.5 mg)
    Figure 13. Global Palonosetron Market Share by Type in 2022 & 2028
    Figure 14. Global Palonosetron Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Palonosetron Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Palonosetron Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Palonosetron Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Palonosetron Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Palonosetron Market Share by Type in 2022 & 2028
    Figure 20. United States Palonosetron Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Palonosetron Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Palonosetron Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Palonosetron Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Palonosetron Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Adults
    Figure 26. Product Picture of Children
    Figure 27. Global Palonosetron Market Share by Application in 2022 & 2028
    Figure 28. Global Palonosetron Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Palonosetron Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Palonosetron Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Palonosetron Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Palonosetron Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States Palonosetron Market Share by Application in 2022 & 2028
    Figure 34. United States Palonosetron Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Palonosetron Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Palonosetron Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Palonosetron Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Palonosetron Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America Palonosetron Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Palonosetron Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Palonosetron Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Palonosetron Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Palonosetron Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Palonosetron Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Palonosetron Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Palonosetron Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Palonosetron Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Palonosetron Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Palonosetron Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Palonosetron Value Chain
    Figure 73. Palonosetron Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed